Symbicort and Gemtesa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Symbicort (budesonide; formoterol fumarate dihydrate) and Gemtesa (vibegron). Common drug interactions include headache among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Symbicort and Gemtesa. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Symbicort?

Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. eHealthMe is studying from 114,792 Symbicort users. Check the latest studies of Symbicort.

What is Gemtesa?

Gemtesa has active ingredients of vibegron. eHealthMe is studying from 2,648 Gemtesa users. Check the latest studies of Gemtesa.

On Jul, 10, 2026

17 people who take Symbicort and Gemtesa together, and have interactions are studied.

Symbicort and Gemtesa drug interactions.

What are the common drug interactions of Symbicort and Gemtesa, by gender? *:

female:

Headache (pain in head)
Infusion related reaction
Pain
Arthralgia (joint pain)
Fall
Fatigue (feeling of tiredness)
Sinusitis (inflammation of sinus)
Vomiting
Abdominal pain upper
Chest pain

male:

Dizziness
Fall
Nausea (feeling of having an urge to vomit)
Cerebral haemorrhage (bleeding within the brain)
Death
Eye irritation
Surgery
Visual impairment
Weight increased

What are the common drug interactions of Symbicort and Gemtesa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Abdominal distension
Asthenia (weakness)
Cellulitis (infection under the skin)
Conjunctivitis (pink eye)
Eating disorder
Fall
Fungal infection
Gastric infection (infection of stomach)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Genital discomfort

60+:

Abdominal pain upper
Arthralgia (joint pain)
Visual impairment
Cerebral haemorrhage (bleeding within the brain)
Death
Eye irritation
Fall
Injection site pain
Myalgia (muscle pain)
Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 8 people, 47.06%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.88%
Parkinson's Disease: 1 person, 5.88%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 1 person, 5.88%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 5.88%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.88%
Lung Disorder (lung disease): 1 person, 5.88%
Indigestion: 1 person, 5.88%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 5.88%
Dry Eyes (lack of adequate tears): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Symbicort and Gemtesa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously